# Effects Of Food And Dose Regimen On The Antiviral Effects Of Maraviroc (UK-427,857) In Patients With Human Immunodeficiency Virus

> **NCT00634959** · PHASE2 · COMPLETED · sponsor: **ViiV Healthcare** · enrollment: 37 (actual)

## Conditions studied

- HIV

## Interventions

- **DRUG:** Maraviroc (UK-427,857)
- **DRUG:** Maraviroc (UK-427,857)
- **DRUG:** Maraviroc (UK-427,857)
- **DRUG:** Maraviroc (UK-427,857)
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00634959
- **Lead sponsor:** ViiV Healthcare
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-07
- **Primary completion:** —
- **Final completion:** 2003-12
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2010-11-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00634959

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00634959, "Effects Of Food And Dose Regimen On The Antiviral Effects Of Maraviroc (UK-427,857) In Patients With Human Immunodeficiency Virus". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00634959. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*